Target Name: EPOP
NCBI ID: G100170841
Other Name(s): Elongin BC and polycomb repressive complex 2 associated protein | elongin BC and polycomb repressive complex 2 associated protein | Proline-rich protein 28 | uncharacterized protein C17orf96 | Elongin BC and Polycomb repressive complex 2-associated protein | Uncharacterized protein ENSP00000317905 | EPOP_HUMAN | proline rich 28 | C17orf96 | proline-rich protein 28 | PRR28

EPOP: A Drug Target / Disease Biomarker

EPOP (Epopit鈦?) is a protein that is expressed in various tissues of the body, including the brain, heart, and liver. It is a key regulator of the cell cycle, and is involved in the development and maintenance of cancer.

Epopit鈦? has also been shown to play a role in the regulation of cellular processes that are important for brain function, such as the regulation of neurotransmitter release and the maintenance of cellular stability.

As a result, EPOP has potential as a drug target for a variety of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and depression.

One of the key challenges in developing a drug target for EPOP is the lack of understanding of its full molecular mechanism of action. While several studies have identified the key role of EPOP in the regulation of cell cycle and neurotransmission, more research is needed to understand how it interacts with other molecules to produce its effects.

In addition, the study of EPOP has also identified a potential link between the regulation of cell cycle and the development of cancer. Studies have shown that EPOP is often expressed in various types of cancer, and that its levels are often elevated in these conditions.

Furthermore, the role of EPOP in the regulation of neurotransmission also suggests that it may have potential as a drug target for psychiatric disorders.

In conclusion, EPOP is a protein that has the potential to be a drug target for a variety of neurological and psychiatric disorders. Further research is needed to understand its full molecular mechanism of action and its potential therapeutic uses.

Protein Name: Elongin BC And Polycomb Repressive Complex 2 Associated Protein

Functions: Scaffold protein that serves as a bridging partner between the PRC2/EZH2 complex and the elongin BC complex: required to fine-tune the transcriptional status of Polycomb group (PcG) target genes in embryonic stem cells (ESCs). Plays a key role in genomic regions that display both active and repressive chromatin properties in pluripotent stem cells by sustaining low level expression at PcG target genes: acts by recruiting the elongin BC complex, thereby restricting excessive activity of the PRC2/EZH2 complex. Interaction with USP7 promotes deubiquitination of H2B at promoter sites. Acts as a regulator of neuronal differentiation

More Common Targets

EPOR | Epoxide Hydrolase | EPPIN | EPPK1 | EPRS1 | EPS15 | EPS15L1 | EPS8 | EPS8L1 | EPS8L2 | EPS8L3 | EPSTI1 | EPX | EPYC | EQTN | ER Membrane Protein Complex | ERAL1 | ERAP1 | ERAP2 | ERAS | ERBB2 | ERBB3 | ERBB4 | ERBIN | ERC1 | ERC2 | ERC2-IT1 | ERCC1 | ERCC2 | ERCC3 | ERCC4 | ERCC5 | ERCC6 | ERCC6L | ERCC6L2 | ERCC6L2-AS1 | ERCC8 | EREG | ERF | ERFE | ERG | ERG28 | ERGIC1 | ERGIC2 | ERGIC3 | ERH | ERHP1 | ERI1 | ERI2 | ERI3 | ERICH1 | ERICH2 | ERICH3 | ERICH4 | ERICH5 | ERICH6 | ERICH6-AS1 | ERICH6B | ERLEC1 | ERLIN1 | ERLIN2 | ERLNC1 | ERMAP | ERMARD | ERMN | ERMP1 | ERN1 | ERN2 | ERO1A | ERO1B | ERP27 | ERP29 | ERP44 | ERRFI1 | ERV3-1 | ERVFRD-1 | ERVK-6 | ERVK13-1 | ERVMER34-1 | ERVV-1 | ERVV-2 | ERVW-1 | ESAM | ESAM-AS1 | ESCO1 | ESCO2 | ESCRT-0 complex | ESCRT-I complex | ESCRT-II complex | ESCRT-III complex | ESD | ESF1 | ESM1 | ESPL1 | ESPN | ESPNL | ESPNP | ESR1 | ESR2 | ESRG